Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

黃加璋 (Chia-Chang Huang)

黃加璋(Chia-Chang Huang)圖 複診掛號 初診掛號

[簡介]

  • 學歷
    • 2003 M.D., Department of Medicine, Taipei Medical University
  • 經歷
    現職：
    經歷：
    • - 2013 Attending physician, Department of Medical Education
    • - 2010 Lecturer, Medical School, National Yang-Ming University
    • - 2009 Attending physician, Department of Medical Education and Research
    • - 2008 Fellow, Center of Gerontology and Geriatrics, Taipei Veterans General Hospital
    • - 2006 Chief Resident, Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital
    • - 2003 Resident of Department of Medicine, Taipei Veterans General Hospital
  • 醫療專長
    1. Endocrinology and Metabolism
    2. Gerontology and Geriatrics

[著作]

第一作者

  • Huang CC, Yeh HY, Lin R, Liao TL, Shen HC, Yang YY, Lin HC. Inhibition of visceral adipose tissue-derived pathogenic signals by activation of adenosine A2AR improves hepatic and cardiac dysfunction of NASH mice. Am J Physiol Gastrointest Liver Physiol. 2024 Jan 22. [IF 3.9]

第一加通訊作者

  • Huang CC*, Yeh HY, Lin R, Liao TL, Shen HC, Yang YY, Lin HC. Inhibition of visceral adipose tissue-derived pathogenic signals by activation of adenosine A2AR improves hepatic and cardiac dysfunction of NASH mice. Am J Physiol Gastrointest Liver Physiol. 2024 Apr 1. [IF 4.5]

共同作者

  • Yeh HY, Wu HH, Shen HC, Li TH, Yang YY, Lee KC, Lin YH, Huang CC, Hou MC. Optimal body mass index for protecting middle-aged and elderly patients with fatty liver from future fractures. Endocr Connect. 2024 May 1. [IF 2.6]
  • Shen HC, Pan MH, Huang CJ, Yeh HY, Yang HI, Lin YH, Huang CC, Lee KC, Yang YY, Hou MC. Multiple genetic polymorphisms are associated with the risk of metabolic syndrome, fatty liver, and airflow limitation: A Taiwan Biobank study. Gene. 2024 Nov 15. [IF 2.6]
  • Lin YH, Wang CH, Huang YH, Shen HC, Wu WK, Yeh HY, Huang CC, Su CW, Yang YY, Wu MS, Lin HC, Hou MC. Models incorporating physical, laboratory and gut metabolite markers can be used to predict severe hepatic steatosis in MAFLD patients. Kaohsiung J Med Sci. 2024 Nov 4. [IF 2.7]